Stryker (SYK) Return on Capital Employed Growth (3y) (2012 - 2026)
Stryker (SYK) Return on Capital Employed Growth (3y) (2012 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | ROCE Growth (3y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 183.82 Bn | 176.53 Bn | 6.27 Bn | -1,679.00 |
| 2 | Stryker | 129.01 Bn | 126.13 Bn | 3.81 Bn | 214.00 |
| 3 | Medtronic | 108.52 Bn | 99.30 Bn | 6.41 Bn | 145.00 |
| 4 | Boston Scientific | 68.59 Bn | 67.14 Bn | 3.61 Bn | 355.00 |
| 5 | Edwards Lifesciences | 48.35 Bn | 44.68 Bn | 1.29 Bn | -846.00 |
| 6 | Dexcom | 28.35 Bn | 27.23 Bn | 750.30 Mn | 1,318.00 |
| 7 | GE HealthCare Technologies | 28.11 Bn | 25.82 Bn | 1.98 Bn | -247.00 |
| 8 | Smith & Nephew | 26.89 Bn | 26.32 Bn | - | - |
| 9 | Koninklijke Philips | 24.28 Bn | 21.15 Bn | 2.07 Bn | - |
| 10 | Steris | 21.43 Bn | 20.99 Bn | 697.10 Mn | 362.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 214.00 |
| Dec 31, 2025 | 290.00 |
| Sep 30, 2025 | 28.00 |
| Jun 30, 2025 | 1,447.00 |
| Mar 31, 2025 | 1,783.00 |
| Dec 31, 2024 | 1,791.00 |
| Sep 30, 2024 | -6,564.00 |
| Jun 30, 2024 | -7,057.00 |
| Mar 31, 2024 | 2,486.00 |
| Dec 31, 2023 | 2,444.00 |
| Sep 30, 2023 | 2,174.00 |
| Jun 30, 2023 | 249.00 |
| Mar 31, 2023 | -90.00 |
| Dec 31, 2022 | -187.00 |
| Sep 30, 2022 | -187.00 |
| Jun 30, 2022 | -263.00 |
| Mar 31, 2022 | -251.00 |
| Dec 31, 2021 | -412.00 |
| Sep 30, 2021 | -591.00 |
| Jun 30, 2021 | -451.00 |